Fritextsökning
Innehållstyper
-
DKK 1,3 billion for grand research
Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Per Hammargren, Sales Director, ICU Scandinavia AB
Why are you going to Scanlab and Biotech Forum?
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Digitalisering ger säkrare cancerdiagnoser
Digitalisering ska ersätta mikroskoperingen av vävnadsprover på Gävle sjukhus.
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Enjoy Stockholm - the capital of Scandinavia
Welcome to Stockholm! Built on 14 islands, you are never far from the water in the capital of Sweden. Stockholm offers a wide range of museums, theaters, and at...
-
Virusforskare får Scilifelabpris
Forskningsinstitutet delar i samarbete med tidskriften Science ut pris till unga forskare.
-
Top modern lab to Sahlgrenska
The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.
-
Stig Wall till globalt institut
KVA utser Stig Wall att leda det vetenskapliga rådet för Swedish institute for global health transformation.
-
Addvise byter börs
Laboratorieteknikbolaget flyttar till större handelsplats.
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Scilifelab-bygge klart
Uppsalanodens nya lokaler har invigts.
-
Ny vd på A+ Science holding
Sedan Agneta Franksson lämnade vd-posten på CRO-bolaget i december har företaget letat ny ledare. Nu har de hittat en efterträdare.
-
"An open mind is the key to successful meetings"
Meeting in person is irreplaceble when it comes to finding a new partner. Johan Ohlsson at Venture Valuation is happy with his meetings at Biotech Forum so far ...
-
Ny modell ska identifiera rätt dos litium vid bipolär sjukdom
Ny forskning vid Karolinska institutet kan bidra till att lösa ett stort problem inom behandling av bipolär sjukdom: att hitta rätt dos litium för varje patient.
-
Vaccin mot borrelia kan bli verklighet
Franska Valneva, med tillverkning i Sverige, och amerikanska Pfizer inleder en fas III-studie med ett vaccin mot borrelia. Studien startar redan i år.
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Danisco strengthens its IP team
Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Cancerdödande protein förstärks – med hjälp av spindeltråd
Länge har stora förhoppningar knutits till proteinet p53 som behandling mot cancer, men problemet är att kroppens celler tillverkar det i för liten mängd och at...
BREAKING